The Temple Lung Center performed the first two treatments in the U.S. as part of the AIRFLOW-3 pivotal clinical trial. The trial is evaluating the efficacy of targeted lung denervation, in addition to medical care, to reduce moderate to severe exacerbations and related hospitalizations in patients with COPD. 6ABC-TV produced a story on Temple’s participation in the trial. The report featured Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, and patient Mark Humphreys.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH